scholarly journals Current and Future Treatments in Primary Ciliary Dyskinesia

2021 ◽  
Vol 22 (18) ◽  
pp. 9834
Author(s):  
Tamara Paff ◽  
Heymut Omran ◽  
Kim G. Nielsen ◽  
Eric G. Haarman

Primary ciliary dyskinesia (PCD) is a rare genetic ciliopathy in which mucociliary clearance is disturbed by the abnormal motion of cilia or there is a severe reduction in the generation of multiple motile cilia. Lung damage ensues due to recurrent airway infections, sometimes even resulting in respiratory failure. So far, no causative treatment is available and treatment efforts are primarily aimed at improving mucociliary clearance and early treatment of bacterial airway infections. Treatment guidelines are largely based on cystic fibrosis (CF) guidelines, as few studies have been performed on PCD. In this review, we give a detailed overview of the clinical studies performed investigating PCD to date, including three trials and several case reports. In addition, we explore precision medicine approaches in PCD, including gene therapy, mRNA transcript and read-through therapy.

2019 ◽  
Vol 54 (12) ◽  
pp. 2021-2027
Author(s):  
Reza Vali ◽  
Hasan Ghandourah ◽  
Martin Charron ◽  
Kimiya V. Nezhad ◽  
Yusuaf Omarkhail ◽  
...  

2014 ◽  
Vol 44 (2) ◽  
pp. 533-535 ◽  
Author(s):  
W. T. Walker ◽  
A. Young ◽  
M. Bennett ◽  
M. Guy ◽  
M. Carroll ◽  
...  

1997 ◽  
Vol 117 (2) ◽  
pp. P176-P176
Author(s):  
S MONTEIRO ◽  
A SILVEIRABALBANI ◽  
P NASCIMENTOSALDIVA

2012 ◽  
Vol 50 (4) ◽  
pp. 353-359
Author(s):  
J. Rimmer

Mucociliary clearance is a primary defence mechanism of the airway that can be altered in congenital diseases such as primary ciliary dyskinesia and cystic fibrosis, as well as acquired conditions. This article focuses on primary ciliary dyskinesia and the diagnostic approach to it, which is still evolving.


2021 ◽  
Vol 18 ◽  
pp. 147997312110616
Author(s):  
Mathias G Holgersen ◽  
June K Marthin ◽  
Helle K Johansen ◽  
Kim G Nielsen

Objectives: Primary ciliary dyskinesia (PCD) is a rare congenital disease with defective mucociliary clearance causing frequent and often persistent pulmonary infections. Achromobacter species are opportunistic pathogens renowned for the difficulty of effective treatments and deteriorating effects on lung function. We aimed to describe the occurrence, treatment, and rate of successful eradication of Achromobacter species in patients with PCD. Methods: We retrospectively reviewed 18 years of historical microbiological samples and 10 years of electronic health records for PCD patients in Denmark. Results: We included 136 patients. Twenty-six patients had isolates of Achromobacter species. On average, 5% of the cohort had at least one annual isolate. Infections became persistent in 38% with a median length of 6.6 years leading to a significant number of antibiotic treatments. Resistance toward tobramycin and ciprofloxacin was prevalent. Overall, successful eradication was achieved in 62% of patients. We found the course of lung function significantly worse during persistent Achromobacter species infection than during the two preceding years, but not different to the course in unaffected age-matched controls. Conclusion The prevalence of Achromobacter species in patients with PCD is in line with what has been reported in cystic fibrosis and can occur transiently, intermittently, or develop into a serious persistent lung infection associated with long-term antibiotic treatment.


2019 ◽  
Vol 61 (3) ◽  
pp. 312-321 ◽  
Author(s):  
Weining Yin ◽  
Alessandra Livraghi-Butrico ◽  
Patrick R. Sears ◽  
Troy D. Rogers ◽  
Kimberlie A. Burns ◽  
...  

2015 ◽  
Vol 41 (3) ◽  
pp. 251-263 ◽  
Author(s):  
Mary Anne Kowal Olm ◽  
Elia Garcia Caldini ◽  
Thais Mauad

Primary ciliary dyskinesia (PCD) is a genetic disorder of ciliary structure or function. It results in mucus accumulation and bacterial colonization of the respiratory tract which leads to chronic upper and lower airway infections, organ laterality defects, and fertility problems. We review the respiratory signs and symptoms of PCD, as well as the screening tests for and diagnostic investigation of the disease, together with details related to ciliary function, ciliary ultrastructure, and genetic studies. In addition, we describe the difficulties in diagnosing PCD by means of transmission electron microscopy, as well as describing patient follow-up procedures.


Diagnostics ◽  
2021 ◽  
Vol 11 (6) ◽  
pp. 1063
Author(s):  
Andreia Lucia Pinto ◽  
Ranjit Kaur Rai ◽  
Amelia Shoemark ◽  
Claire Hogg ◽  
Thomas Burgoyne

Primary ciliary dyskinesia (PCD) is a disorder affecting motile cilia. An early accurate diagnosis helps prevent lung damage and preserve lung function. To make a diagnostic assessment, one of the commonly used methods that allows for the examination of ciliary ultrastructure is transmission electron microscopy (TEM). This allows for a quantitative assessment of ciliary components to identify defects associated with PCD. Heavy metal staining is required to provide a contrast when imaging cilia in the TEM. One of the most commonly used stains is uranyl acetate (UA). UA can be applied to cellular material before embedding (en bloc), or to ultrathin sections of embedded samples (grid staining). UA is radioactive and, due to growing safety concerns and restrictions by government bodies, universities and hospitals, it is essential to find a suitable alternative. We show UA-zero (UAZ), when used en bloc, provides a high contrast and is a suitable replacement for UA. PCD diagnostic experts, having reviewed ciliary cross-sections stained with UAZ en bloc, are confident that the staining and PCD defects are readily detectable similar to samples that have been stained with UA.


2014 ◽  
Vol 50 (2) ◽  
pp. 179-186 ◽  
Author(s):  
Massimo Pifferi ◽  
Andrew Bush ◽  
Angela Michelucci ◽  
Maria Di Cicco ◽  
Martina Piras ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document